🇺🇸 FDA

Company profile · Sponsor

Chinese

Chinese University of Hong Kong

CB77565 · NMPA pharma CN
Pipeline
24
Drugs
0
Patents
0

Quick answer

Chinese (CB77565) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CB77565
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (24)

Search pipeline →

  1. Acu-TENS

    Chinese

    Pain

    phase 3 other completed

    1 trial

  2. Endoscopic submucosal dissection

    Chinese

    Colorectal Neoplasms

    phase 3 other active

    1 trial

  3. Epinephrine

    Chinese

    Gastric Neoplasm

    phase 3 small molecule completed

    1 trial

  4. Tissue Plasminogen Activator

    Chinese

    Pleural Infection

    phase 3 small molecule active

    1 trial

  5. Unified protocol for adolescents (UP-A)

    Chinese

    Depressive Disorder

    phase 3 other completed

    1 trial

  6. paricalcitol

    Chinese

    IgA Nephropathy

    phase 3 small molecule terminated

    1 trial

  7. Almonertinib 110 MG

    Chinese

    Rare Tumor

    phase 2 small molecule active

    1 trial

  8. Apatinib

    Chinese

    Head and Neck Neoplasms

    phase 2 small molecule active

    1 trial

  9. Apatinib Mesylate +SHR-1210

    Chinese

    Hepatocellular Carcinoma

    phase 2 other active

    1 trial

  10. Chinese Herb

    Chinese

    COVID-19

    phase 2 small molecule active

    1 trial

  11. Chinese Medicine Oral Rinse Formula-I (CMORF-I)

    Chinese

    Head and Neck Neoplasms

    phase 2 small molecule active

    1 trial

  12. Cisplatin and Doxorubicin

    Chinese

    Gastric Cancer Peritoneal Metastases

    phase 2 small molecule active

    1 trial

  13. Colon originated: Neostigmin, Colonoscopy decompression, Surgery

    Chinese

    Acute Lower Gastrointestinal Dysfunction

    phase 2 other active

    1 trial

  14. Fezolinetant

    Chinese

    Vasomotor Symptoms

    phase 2 small molecule active

    1 trial

  15. Fludrocortisone 100 mcg daily

    Chinese

    Sepsis

    phase 2 small molecule active

    1 trial

  16. Iparomlimab/Tuvonralimab

    Chinese

    LOCALLY ADVANCED CERVICAL CANCERS

    phase 2 small molecule active

    1 trial

  17. Nimotuzumab

    Chinese

    Esophageal Cancer

    phase 2 small molecule completed

    1 trial

  18. Per-Oral Endoscopic Myotomy

    Chinese

    Primary Esophageal Motility Disorders Including Achalasia and Hypertensive LES

    phase 2 other active

    1 trial

  19. Programmed Cell Death Protein 1 Inhibitor

    Chinese

    Locally Advanced Esophageal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  20. RC48-ADC

    Chinese

    Muscle Invasive Bladder Carcinoma

    phase 2 small molecule active

    1 trial

  21. SIRT Yttrium-90

    Chinese

    Cholangio Carcinoma

    phase 2 small molecule completed

    1 trial

  22. rituximab

    Chinese

    Systemic Lupus Erythematosus

    phase 2 small molecule completed

    1 trial

  23. Amlodipine, Telmisartan, Amiloride Compound , Simvastatin

    Chinese

    Essential Hypertension

    approved small molecule active

    1 trial

  24. Baricitinib 4 MG

    Chinese

    Rheumatoid Arthritis

    approved small molecule active

    1 trial

Frequently asked questions

What is Chinese?

Chinese (CB77565) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Chinese sponsor?

We track 24 ClinicalTrials.gov-linked programs for Chinese, including Acu-TENS and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Chinese company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.